Innovative Medicine
-
-
Janssen Collaborates with Premier Inc. on Unique Study to Improve Stroke Risk Management among Hospitalized Patients with Atrial Fibrillation
The QUANTUM AF study will evaluate the impact of a hospital quality improvement program on the use of new guidelines to treat patients with atrial fibrillation (AF) at risk for ischemic stroke -
Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge
Challenge awards up to $200,000 to novel solutions that advance safety by informing patients and consumers, simulating surgical procedures or ensuring proper storage and use of prescription, over-the-counter and cosmetic products -
Janssen Discontinues Development of Flubendazole Formulation to Treat Onchocerciasis
Research supported Johnson & Johnson’s commitment to the 2012 London Declaration on Neglected Tropical Diseases and yielded important findings -
-
-
-
Johnson & Johnson Names Winners of First Africa Innovation Challenge
Competition Part of Company’s Eighty-Five Year Commitment to Supporting Entrepreneurs, Science Education Opportunities, and Health Systems Across the Continent -